chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pulmonary embolism; shortness of breath and chest with deep breaths; shortness of breath and chest with deep breaths; Dose Number: 3; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Oct2021 16:00 (Lot number: 3203060) at the age of 59 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "History of DVT" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID]; FLUOXETINE. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9264, Location of injection: Arm Left), administration date: 30Jan2021, when the patient was 59 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0142, Location of injection: Arm Left), administration date: 08Jan2021, when the patient was 59 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (disability) with onset 14Oct2021 16:00, outcome "unknown", described as "Dose Number: 3"; PULMONARY EMBOLISM (disability) with onset 01Nov2021, outcome "not recovered", described as "Pulmonary embolism"; DYSPNOEA (disability), CHEST PAIN (disability) all with onset 17Oct2021, outcome "not recovered" and all described as "shortness of breath and chest with deep breaths". The events "pulmonary embolism", "shortness of breath and chest with deep breaths" and "shortness of breath and chest with deep breaths" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (01Nov2021) negative, notes: If covid tested post vaccination: Yes. Therapeutic measures were taken as a result of pulmonary embolism, dyspnoea, chest pain.  Clinical course: The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 since the vaccination.
Immediate shooting pains throughout body (felt like electric sparks) - would feel pain for about 30 seconds, then it would subside, then the pain would move to another area of the body. After a few days, the shooting pains subsided, but there was tingling and numbness in my left arm and leg, which persisted for 3 weeks. My doctor thought it could be GBS.
After about 26 hours Fever of 102, chills, fatigue, aches, headache. All lasted for about 48 hours. On July 31 rash developed on left arm around injection site of pneumococcal vaccine that was administered the same time as shingles vax
Pain in arm; Headache; Nausea; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Low grade fever) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not provided) for COVID-19 vaccination.     Concurrent medical conditions included Pulmonary fibrosis, Emphysema and COPD.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in arm), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Low grade fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications with H/O pulmonary fibrosis, emphysema, and  COPD. Treatment details included None.  Action taken with mRNA-1273 in response to the events was not applicable.
Extreme nausea, dizziness, headache, low fever, stomach pains, soreness at sight and arm for days. Extreme fatigue first 4 days after vaccine. Still have headaches. Sore throat and upper respiratory infection and loss of voice came about 3 to 4 days after vaccine. Still feel horrible and have headaches. It is June 12th and I am now sick with sore throat and other symptoms mentioned above. My headache comes and goes. Never had headaches ever in my life, until now!
Fever, body aches, headache started about 20 hours after shot and lasted about 20 hours
Pt to ED  for chest pain over the left side of her chest and states that she started having pains today on the right side of her chest and ribs. Breathing regular, unlabored. No s/s distress noted. 2/27 pt AOx4, pleasant & cooperative, external catheter applied to pt, denied pain. 2/28 pt denied continuation of chest pain. Pt discharged 3/1 to Facility.
Rhabdomyolysis Went to the hospital and they gave me saline solution for 3 days because my CK numbers went up to 99k.  At discharge CK numbers were at 33k but was sent home to drink 3 64 OZ of water per day.
RASH AT INJECTION SIGHT, SWOLLEN FACE, NAUSEA AND DIARRHEA.
This spontaneous report was received from a physician referring to a 13 month old patient. In May 2017 (reported as "three months ago"), the patient was vaccinated with PROQUAD for prophylaxis (drug administered to patient of inappropriate age).  Concomitant therapies included sterile diluent(DILUENT MRK). No adverse event reported.
Narrative: Patient reported throat itching that started before receiving the pfizer covid vaccine. This was likely not the result of the covid vaccine based on it starting before the vaccine.
Pruritic rash of arms, legs, upper chest that began approximately 20 hours after the vaccine was given.  Initial treatments of hydrocortisone cream, calamine and oral benedryl did not help symptoms. Depo Medrol administered in the office. Prescription given for oral prednisone taper.
fever ( 4 days); headache, backache, abdominal pain, diarrhea, nausea (7 days); weakness and fatigue (10 days)- symptoms treated with OTC medications and bedrest
With previous 2 it was just sore around the deltoid  2 the days later the pain (like after a cramp) has spread around the whole armpit and in inch in to the left back and chest
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-NOV-2015, the patient was vaccinated with the improperly stored dose of (Oka/Merck) VARIVAX (lot # L019130, expiration date 27-MAY-2017; dose and route of administration were not reported). No adverse reactions were reported. Additional information has been requested.
pt recv vax 22APR97 & 22APR97 pt exp redness, heat, & swelling in legs, hives on foot;
Information has been received from a 27 year old female licensed practical nurse with no pertinent medical history and no drug reactions or allergies who on 03-FEB-2011 got some VARIVAX (Merck) (Lot 668587/1184Z# and expire date not reported) into her eyes as she was administering a dose to a patient. There was no concomitant medication. Licensed practical nurse stated that it was a very small amount, "like a mist". She had finished administering the dose of VARIVAX (Merck) and as she was taking the needle out of patient's arm, "patient jerked little bit and some mists or very small drops got into her eyes". Licensed practical nurse stated that flushed her eyes with water after the incident. Licensed practical nurse felt some dryness in her eyes. No other adverse reactions were reported. No treatment was given to the licensed practical nurse. There were no laboratory diagnostics studies performed. Additional information has been requested.
sluggish; Left arm still red; very itchy; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (sluggish), ERYTHEMA (Left arm still red) and PRURITUS (very itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No medical history was provided by the reporter.     On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (sluggish), ERYTHEMA (Left arm still red) and PRURITUS (very itchy). At the time of the report, SLUGGISHNESS (sluggish), ERYTHEMA (Left arm still red) and PRURITUS (very itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Blurred vision and dizziness immediately after vaccine and for following day.   Off and on for the next 3 days.
With the 1st shot arms got heavy; Couldn't move arms for about 4 min; The next 2 days I felt like an oven door was opened inside me. Very hot inside but outside body was cool; This is a spontaneous report from a contactable 60-year-old female (Nurse). A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot no: EL1283) via intramuscular administration, administrated in right arm on 12Jan2021 11:15 AM, as single dose and second dose (Batch/Lot no: EL3302) via other route administrated in right arm on 02Feb2021 12:15 PM as single dose for COVID-19 immunization. The patient medical history included depression Depression, Hypothyroidism, High Cholesterol, Osteopenia, Occasional vertigo. The patient concomitant medications included Simvastatin 40mg, Duloxetine 30-60mg, Raloxifene 60mg, Chlorthalidone 25mg, Levothyroxine 0.88mcg, Calcium 600mg with 500IU Vitamin D, Folic Acid 400mcg, Fish Oil 1400mcg, B12 5000mcg, Vitamin D 2000IU and Tumeric 1000mg. The patient had second dose on 02Feb2021. After the first dose patient experienced patient arms got heavy and then pateint couldn't move them for about 4 min. The next 2 days patient felt like an oven door was opened inside. Very hot inside but outside body was cool, no redness or sweating.  patient 2nd shot on arms didn't get heavy, just felt a weakness going from shoulders down to hands. Couldn't move or feel them for 15 min. Slowly patient could move fingers then hands then lift arms. The next day patient brain felt kind of fuzzy. Still a little "off kilter" on 2nd day. Patient did not have any anxiety about either shot, even with what happened with the first one. (patient the one reporting - it says patient from a healthcare professional reporting for a patient and patient couldn't change it). Prior to vaccination, was the patient did not diagnose with COVID-19. Since the vaccination, the patient had been not tested for COVID-19. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021136873 Same patient, same drug, different vaccine date
Information has been received from a physician concerning a 7 year old female who on 06Jul98 was vaccinated with a dose of varicella virus vaccine live (lot625385/0312H). The physician reported that on 16Mar05, the pt developed a mild case of breakthrough characterized by 5-6 lesions but no fever. The pt was seen by the physician and was given diphenhydramine HC1 (Benadryl) in the case of itching. At the time of this report, the pt's mild case of breakthrough persisted as she was still breaking out. Additional information has been requested.
Broke out in hives; A rash in several places; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 21Apr2021 at 09:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and any other illness. The patient had known allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks, prior to vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 09:00(at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 19:00 the patient experienced broke out in hives and a rash in several places. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events broke out in hives and a rash in several places was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Day of vaccine there was localized swelling. The next 3 days, swelling site got more red and larger. Day 2, entire body had a rash. Extreme crankiness & crying w/low grade fever, 99.9.
patient got pfizer (booster for Janssen) on 10/26, he also got Fluzone  Quad, about a week later he had a heart attack at 7:15 AM 11/2/21. After some CPR he was taken by ambulance to a local Hospital ER. He was later transported to another  Hospital. He passed away the same day
Fever of 104.6, sweating, muscle pain, joint stiffness, swollen lymph nodes, pressure in the head, racing heart rate, and elevated blood pressure. After taking Ibuprofen, temperature went down to 96.6 with cold sweat.
Fatigued, soar, flew like symptoms for a week.  Out break of shingles on back of neck. Medication for 3 xs a day for 8 days was prescribed which helped with the itching and pain. Proctosol-HC 2.5% cream
Rash on right arm, rash/urticaria under Dexcom, rash on right side of face.
This spontaneous report was received from a licensed practical nurse refers to multiple unspecified patients of unknown ages and genders. Concurrent conditions and medical history were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of (Merck) VARIVAX injection, lot # L015045, expiration date reported as 29-APR-2017 and L017144, expiration date reported as 13-MAY-2015 (strength, dose, route of administration, anatomical location were not reported). No adverse effects were reported. Additional information has been requested.
This spontaneous report as received on 18-JUL-2016 from a female physician who left a message on the voice mail of the male company representative refers to several unspecified patients of unknown age and gender who experienced syncope after administration of the vaccination GARDASIL 9 (Date of administration, dose, route of administration, anatomical location, lot # and expiry date were not specified). The patients' sought medical attention (unknown type of medical attention and unknown dates). No information about the patients' pertinent medical history or allergies was reported. No information was reported on concomitant medications. The outcome of the event of syncope was unknown. Additional information is not expected.
States she began having very itchy bumps over her extremities, neck and some on trunk begining approximately 2 weeks after receiving the vaccine. She continued to get them for 2-3 more weeks. They are resolving now with only scarring remaining.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX for prophylaxis. On an unknown date the patient experienced product use issue. The outcome of product use issue is unknown.   The reporter considered product use issue to be not related to ZOSTAVAX. {Additional information has been requested. / Additional information is not expected.}
She had pain in right arm and right leg; A patient received the contents of the entire vial of undiluted Pfizer-Biontech Covid19 vaccine earlier this afternoon as her second dose; A patient received the contents of the entire vial of undiluted Pfizer-Biontech Covid19 vaccine earlier this afternoon as her second dose; This is a spontaneous report from a contactable physician. A 21-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EN6205), via an intramuscular on 07Mar2021 at 12:45 (at age of 21-years-old) as single dose, for COVID-19 immunization. The patient's medical history included migraine and covid-19 (prior to vaccination). The patient was not tested post vaccination. The patient's concomitant medications included amitriptyline and estradiol (ESTROGEN). The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On 07Mar2021, the patient received the contents of the entire vial of undiluted Pfizer-Biontech Covid19 vaccine earlier this afternoon as her second dose. On 08Mar2021, the patient had pain in right arm and right leg but no other side effects. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Pt received first dose of Pfizer vaccine lot EL1238.  Ambulated to seat independently post vaccination.  Approximately 3-5 minutes post vaccine SM began feeling dizzy and light headed with diaphoresis.  Pt was moved to alcove and seated in a chair for monitoring.  Pt stated no medical history but did feel dizzy with last flu vaccine.  As this writer was connecting monitoring patient lost consciousness, noted pupils largely dilated.  Lowered to floor by this writer and security office.  Legs were elevated with immediate return of consciousness. Rapid called for assistance. Orthostatic vital monitored.  When patient returned to floor began feelings that he was again losing consciousness.  Lowered back to floor without loss of consciousness.  Orthostatic vitals completed again. Pt moved to cart.  Monitored for additional lying to siting to standing with complete resolution of symptoms.  Pt left for home ambulatory and declined this writer to accompany to vehicle or call a family member.    VS Time     HR     B/P     SpO2 1357     74     125/72      100%  lying 1359     90     148/83     100%   laying 1401     85     151/85     100%   sitting on floor 1402     82     129/78     100%   chair 1404     71     132/70     100%   lowered back to floor blood sugar 111 @1407 1410     78     132/79     100%   moved to cart 1415     82     132/81     100%   laying 1420     74     135/83     99%     sitting 1426     83     132/89     100%   dangle 1430     86     129/76     99%   standing / marching in place
Flu-like symptoms, chills, dizziness, muscle aches, lethargic. Downright crappy. Had to rest on the sofa all day with a blanket because I kept having chills.
No Wheal and observed leakage on first Intradermal administration. 2nd administration was successful subcutaneously.
Child received dose 1 of Pediatric 5-11 YR dose of Covid-19 vaccine today (Pfizer) in clinic.  After vaccination approximately 9:40 AM father alerted nurse to child pale, not feeling well, and had vomited in waiting area after vaccine. Child noticeably pale.  Fainting protocol initiated per department protocol. Child was assisted to lay down on exam table. Vital Signs taken and stable (blood pressure 91/61 ,heart rate 82, and oxygen saturation 99% on room air).Child remained awake and responsive throughout entire event. Child given juice and crackers. With interventions, color began to return to baseline.  Child closely monitored for 30 minutes. Child had returned to baseline and stable upon leaving clinic to go home with father.   Nurse Manager called and spoke to mother at 3:10 Pm on 11/10/21. Mother states child doing well with no symptoms. Denies any adverse reactions. States child is busy playing. Mother is grateful and denies questions or concerns at this time.
Patient brought to the ED via EMS on 7/15 for weakness, fever, and fatigue. While in the ED, he became hypoxic to about 84% and was placed on oxygen by NC. COVID-19 PCR swab in the ED was positive. Patient was admitted for further COVID related cares given his hypoxia, and was admitted 7/15-7/18. He was diagnosed with acute hypoxic respiratory failure due to COVID-19. He is vaccinated against COVID-19. This meets criteria for vaccine breakthrough case review.
Large Redness on the Right Arm from Shoulder to Elbow; Itching Right Arm from Shoulder to Elbow; Sore Lymph node under arm; Fever 99.5 F; Shortness Of Breath; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness Of Breath), ERYTHEMA (Large Redness on the Right Arm from Shoulder to Elbow), PRURITUS (Itching Right Arm from Shoulder to Elbow), LYMPH NODE PAIN (Sore Lymph node under arm) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 18-Dec-2020.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced DYSPNOEA (Shortness Of Breath) and HEADACHE (Headache). On 27-Feb-2021, the patient experienced ERYTHEMA (Large Redness on the Right Arm from Shoulder to Elbow), PRURITUS (Itching Right Arm from Shoulder to Elbow), LYMPH NODE PAIN (Sore Lymph node under arm) and PYREXIA (Fever 99.5 F). On 08-Mar-2021, ERYTHEMA (Large Redness on the Right Arm from Shoulder to Elbow), PRURITUS (Itching Right Arm from Shoulder to Elbow), LYMPH NODE PAIN (Sore Lymph node under arm), HEADACHE (Headache) and PYREXIA (Fever 99.5 F) had resolved. At the time of the report, DYSPNOEA (Shortness Of Breath) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Dec-2020, SARS-CoV-2 test: positive (Positive) Positive. On 27-Feb-2021, Body temperature: 99.5 (High) 99.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.  Patient stated that her breathing was better but she was still having issues. Patient also stated that on 27-Feb-2021 she had a significant reaction.
Initial unsolicited report received from a consumer on 15-Nov-2016. This case involves a 65-year old female patient who was vaccinated with first dose of FLUZONE HD (Batch number, expiry date, dose, route, dose in series were not reported) in left deltoid on an unknown date. Patient's pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) includes Soy, Formaldehyde, Pcn, Wheat, Corn , Allergies to 70 items. It was also reported that patient had no illness at the time of vaccination. Concomitant medications was not reported. It was also reported that any other vaccinations within four weeks of vaccinations was none. On an unknown date, within 15-minute following the vaccination, patient began vomiting profusely but went to home. Since then patient had migraines, runny nose, and body aches cough with wheezing. Patient required emergency room (ER)/ doctor visit. Laboratory investigations were not reported. Patient did not required corrective treatment. The outcome of event was reported as not recovered. List of documents held by sender: none.
The day after I got my 2nd covid vaccine, I lost my sense of taste and smell. I did have covid in January and lost my sense of taste and smell, but got it back once I tested negative. But since the vaccine, I have not gotten my smell or taste back.